A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

Novo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...

Significant’ weight returned weeks after stopping drug, say researchers who advise patients to adjust expectations.

Deal-signing at the German cloud computing and software giant SAP turned cautious in the second quarter, CFO Dominik Asam ...

Reporting on a non-IFRS basis, the company behind the Concur travel and expense-management platform said total revenue rose 12% at constant currencies to 9.03 billion euros ($10.61 billion) from the ...

BERLIN] SAP reported quarterly cloud and software sales that fell just short of estimates as tariff insecurities weighed on ...

Everybody wants their hands on NVIDIA's GPUs, with the AI favorite continuing to ink fresh deals and collaborate with many ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.

Here are nine new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...